Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Labcorp Holdings's share price for the quarter that ended in Mar. 2026 was $264.49. Labcorp Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 82 Mil. Therefore, Labcorp Holdings's market cap for the quarter that ended in Mar. 2026 was $21,768 Mil.
Labcorp Holdings's quarterly market cap
declined
from Sep. 2025 ($23,643 Mil) to Dec. 2025 ($20,712 Mil) but then
increased
from Dec. 2025 ($20,712 Mil) to Mar. 2026 ($21,768 Mil).
Labcorp Holdings's annual market cap
increased
from Dec. 2023 ($19,066 Mil) to Dec. 2024 ($19,203 Mil) and
increased
from Dec. 2024 ($19,203 Mil) to Dec. 2025 ($20,712 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Labcorp Holdings's Enterprise Value for Today is $28,975 Mil.
Labcorp Holdings (LTS:0JSY) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Labcorp Holdings Market Cap Related Terms
Labcorp Holdings Market Cap Historical Data
* Premium members only.
The historical data trend for Labcorp Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Labcorp Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labcorp Holdings Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Labcorp Holdings's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Labcorp Holdings's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labcorp Holdings (LTS:0JSY) has a Market Cap of $22,698 Mil as of Jul. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Labcorp Holdings and its competitors. According to the industry distribution chart, Labcorp Holdings ranks #13 out of 217 companies in the Medical Diagnostics & Research industry, placing it in the top 6%.
Is Labcorp Holdings' Market Cap too high?
Labcorp Holdings' current Market Cap is $22,698 Mil. The Medical Diagnostics & Research industry median Market Cap is 61.65. Labcorp Holdings' value of $22,698 Mil is 36720.5% above this industry median. Based on the distribution chart, Labcorp Holdings ranks #13 out of 217 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Labcorp Holdings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' Market Cap compare to DGX and GH?
According to the Medical Diagnostics & Research industry distribution chart, Labcorp Holdings ranks #13 out of 217 companies for Market Cap. This places Labcorp Holdings in the top 6% of its industry — outperforming the majority of peers. The industry median Market Cap is 61.65. Labcorp Holdings' value of $22,698 Mil is 36720.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 61.65, based on 217 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labcorp Holdings's current Market Cap of $22,698 Mil is 36720.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Labcorp Holdings and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 61.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labcorp Holdings's current Market Cap is $22,698 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LTS:0JSY) is currently considered Fairly Valued. The stock's GF Value™ is $269.82, compared to a current price of $278.87 — trading 3.4% above its estimated fair value. The current Market Cap is $22,698 Mil and 36720.5% above the Medical Diagnostics & Research industry median of 61.65. Labcorp Holdings' overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Labcorp Holdings (LTS:0JSY), the current Market Cap is $22,698 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Labcorp Holdings (LTS:0JSY) Overvalued in 2026?
Based on GuruFocus' analysis, Labcorp Holdings stock appears to be overvalued.
The current stock price of $278.87 is trading 3.4% above its estimated GF Value™ of $269.82.
GuruFocus considers Labcorp Holdings to be Fairly Valued.
Key valuation signals for LTS:0JSY:
Market Cap: $22,698 Mil
GF Value™: $269.82 vs. price of $278.87 (3.4% above fair value)
Industry Position: 36720.5% above the Medical Diagnostics & Research median (#13 of 217)
No single metric tells the full story. See the LTS:0JSY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
81GF Score
Get the complete analysis for LTS:0JSY
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0JSY has been successfully added to your 
